Physician profile
Nancy Quintero
NPI 1528141835
$362.58
in general payments reported to CMS, 2019-2025
14 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2023: $55.12 · 2024: $45.58 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $47.83 | 2019 | |
| Novo Nordisk INC | $39.58 | 2019-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $38.86 | 2019-2025 | Eliquis |
| Glaxosmithkline, LLC. | $36.81 | 2019-2025 | Bexsero, Arexvy, Shingrix |
| Abbvie INC. | $27.18 | 2025 | |
| Dexcom, INC. | $25.15 | 2023 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $22.79 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.79 | 2024 | Caplyta |
| Dynavax Technologies Corporation | $22.65 | 2025 | Heplisav-B |
| Exact Sciences Corporation | $18.45 | 2025 | The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $15.94 | 2019 | |
| Lilly USA, LLC | $15.08 | 2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $14.89 | 2023 | Breztri |
| Merck Sharp & Dohme LLC | $14.58 | 2025 | Capvaxive, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Quintero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.